Borofalan (also known as SPM 011) is an adjuvant compound used in boron neutron capture therapy (BNCT) for cancer treatment. BNCT leverages the high neutron capture cross-section of boron-containing compounds (10 B) and facilitates the 10 B(n,alpha) 7 Li neutron capture and nuclear fission reaction. With the use of borofalan (10B)-containing C-BENS, BNCT has demonstrated effective therapeutic potential in patients with R-SCC or R/LA-nSCC of the head and neck. Note: We offer the non-labeled version of Borofalan.
Molekulargewicht:
245.47
CAS Nummer:
[76410-59-8]
Formel:
C9H13BClNO4
T202995
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten